Editorial
|
|
|
Learning to be wary of medicines
|
|
|
New Products
|
|
|
Short-term benefit, unknown long-term risks
|
|
|
|
|
|
|
|
|
|
|
Endometriosis: still no progress
|
|
|
Adverse Effects
|
|
|
Antiepileptics, calcium channel blockers, immunosuppressants
|
|
|
|
|
|
|
Patient empowerment is essential
|
|
|
|
|
|
Re-assess treatment regularly
|
|
|
|
|
|
Do not use in multiple sclerosis
|
|
|
|
Reviews
|
|
|
Diagnostic competence
|
|
|
|
|
|
|
|
|
Symptomatic infection requires treatment
|
|
|
Outlook
|
|
|
Training in marketing tools is needed
|
|
|
|
|
|
|
Study reveals a correlation
|
|
|
|
|